SEC Form 4 · accession 0001179110-17-002432
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Meury
Officer — Chief Commercial Officer
Period of report
Dec 8, 2016
Accepted (ET)
Feb 14, 2017 · 9:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001 | Dec 8, 2016 | M | 11,807 | $109.12 | A | 48,866 | D | |
| Ordinary Shares, par value $0.0001F1 | Dec 8, 2016 | F | 9,414 | $188.47 | D | 39,452 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) | $188.47 | Dec 8, 2016 | M | 11,807 | D | Dec 8, 2016 | Dec 8, 2016 | Ordinary Shares | 11,807 | 0 | D |
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.